🚨 The Dilution Paradox: Why a $7M Debt Facility Demolishes the Short Script
There is a glaring, mathematically impossible contradiction sitting directly inside the current short narrative. For the last month, the uniform script plastered across the message boards has been that management is aggressively diluting at the market floor just to keep the lights on.
If that narrative were true, the company would have a steady stream of liquid cash flowing directly onto the operational balance sheet from those open-market equity sales. They would have absolutely no reason to borrow capital.
Yet, the Q1 10-Q filed on May 15, 2026 contains a explicit Subsequent Event disclosure: In May 2026, the company bypassed equity issuance and entered into a $7 million commercial loan agreement.
1. The Underwriting Reality Check
Commercial bank lenders do not operate on hope, hype, or board rumors. They do not issue multi-million dollar credit facilities to pre-commercial companies facing imminent bankruptcy or death-spiral liquidation. To secure a clean, non-dilutive $7,000,000 line of credit, management had to submit to a rigorous, institutional underwriting discovery process. The lender's compliance officers had to thoroughly audit the company's real collateral—including the asset data packets and the UK regulatory trajectory—and mathematically verify a de-risked path to commercialization before authorizing that cash release.
2. The Bridge vs. The Bleed
Why take debt if institutional sovereign capital is aligning? Because of the structural clearance gap. In massive sovereign placements or block ledger allocations, the legal execution of share structures happens weeks or months before the corresponding capital can clear restricted escrows and hit available operational checking accounts.
Meanwhile, physical building costs at The London Welbeck Hospital clinic (scaling up for 4 patients a day this June) and the Sawston Grade C suites require live, weekly cash settlement.
Taking a $7 million commercial note is the classic definition of an operational bridge financing mechanism.
Linda has a documented SEC history of structuring these commercial notes with massive amortization holidays and upfront Original Issue Discounts (OID)—meaning the cash hits the account immediately, but the principal repayments are frozen for months.
3. The Bottom Line
The bears can’t have it both ways. A company running a toxic, un-backed dilution scheme cannot simultaneously command millions in clean, non-convertible commercial bank debt. The presence of that May loan proves that management is actively ring-fencing the equity ledger, locking out market-maker dilution arbitrage, and building a secure cash bridge to sustain peak operational velocity right up to the regulatory finish line.
Market Data 
Markets 
